Tradestie Institutional Equity Comparison Engine

ARVN vs ALEC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ALEC Overall Edge

ALEC Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alector, Inc. Common Stock (ALEC) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ARVN trades at 17.9x Forward P/E with -10.1% operating margin (-98.8% YoY revenue) versus ALEC at 8.5x Forward P/E and 21.8% operating margin (+4895.9% YoY). In options structure, ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against ALEC sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ALEC
ARVN 17.9x vs ALEC 8.5x Fwd P/E
Growth & Margin Winner ALEC
Op Margin -10.1% vs 21.8% ยท YoY -98.8% vs +4895.9%
Momentum & Technical Winner ALEC
1Y -33.4% vs +112.1% ยท 52W Pos 5% vs 83%
Options & Structure Winner ALEC
BREAKDOWN (25th %ile IV) vs CONSOLIDATION (9th %ile IV)
ARVN NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap $449.9M
1M Return -3.3%
1Y Return -33.4%
Forward P/E 17.9x
Unified AI Score
52.9 / 100 HOLD
Tech 54.0 Fund 59.0 Flow 71.0 Mom 54.0
ALEC NASDAQ
Alector, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$2.54
+0.2% 1D
Market Cap $364.7M
1M Return +38.32%
1Y Return +112.08%
Forward P/E 8.5x
Unified AI Score
37.0 / 100 SELL
Tech 50.0 Fund 34.0 Flow 64.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ARVN -33.4% ALEC +112.08% Spread: +145.48 pp (ALEC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ARVN Revenue ALEC Revenue ARVN Op. Margin ALEC Op. Margin Margin Edge
FY2018 $10M $30M -306.3% -208.3% ALEC
FY2019 $20M $20M -281.4% -539.2% ARVN
FY2020 $20M $20M -554.1% -925.1% ARVN
FY2021 $50M $210M -403.4% -18.0% ALEC
FY2022 $130M $130M -200.3% -103.2% ALEC
FY2023 $80M $100M -511.5% -156.3% ALEC
FY2024 $260M $100M -95.0% -144.2% ARVN
FY2025 $260M $20M -45.1% -741.3% ARVN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ARVN (3) vs ALEC (7)
Institutional Metric ARVN ALEC Criterion Row Winner
Market Capitalization Scale $449.9M $364.7M Larger Scale ARVN
Trailing P/E Ratio Valuation 17.9x 6.6x Lower Multiple ALEC
Forward P/E Ratio Valuation 17.9x 8.5x Lower Multiple ALEC
Revenue Growth (YoY) Growth -98.8% +4895.9% Higher Growth ALEC
Operating Margin (TTM) Profitability -10.1% 21.8% Higher Margin ALEC
Net Profit Margin Profitability -3.5% 23.9% Higher Margin ALEC
Return on Equity (ROE) Capital Efficiency -1.8% 47.5% Higher ROE ALEC
52-Week Range Position Momentum 5% ($6โ€“$15) 83% ($1โ€“$3) Stronger Trend ALEC
Beta / 30D Volatility Risk Regime 1.40ฮฒ ยท 66% Vol 1.58ฮฒ ยท 95% Vol Lower Realized Risk ARVN
Unified Institutional Score Composite Signal 52.9 / 100 (HOLD) 37.0 / 100 (SELL) Higher Composite ARVN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ARVN vs ALEC Buy Guide
ARVN BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ARVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ALEC CONSOLIDATION
52d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live ALEC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ARVN nor ALEC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.